EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer

Jia Yan, Ruyi Lin, Qiyu Liu, Yatong Zhang, Hao Chen, Fan Tong, Yujun Song, Yulong Shi, Yuan Li

Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7573-7588

DOI: 10.1016/j.apsb.2026.07.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Jia Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CpGHydrogelImmunotherapyLymph node targetingNanovaccineOvarian cancerPD-1Whole-cell tumor antigens

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
  • Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.

Förderung

  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation

Zitieren

APA

Yan, J., Lin, R., Liu, Q., Zhang, Y., Chen, H., Tong, F., Song, Y., Shi, Y., & Li, Y. (2026). In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer. Acta Pharmaceutica Sinica B, 16(11), 7573-7588. https://doi.org/10.1016/j.apsb.2026.07.030

Vancouver

Yan J, Lin R, Liu Q, Zhang Y, Chen H, Tong F, et al. In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer. Acta Pharmaceutica Sinica B. 2026;16(11):7573-7588. doi:10.1016/j.apsb.2026.07.030

BibTeX
@article{Yan2026,
  author = {Yan, Jia and Lin, Ruyi and Liu, Qiyu and Zhang, Yatong and Chen, Hao and Tong, Fan and Song, Yujun and Shi, Yulong and Li, Yuan},
  title = {In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {7573--7588},
  doi = {10.1016/j.apsb.2026.07.030}
}
Kostenlos starten →